151 related articles for article (PubMed ID: 22746224)
1. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia.
Lai HM; Sitharthan T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):567-74. PubMed ID: 22746224
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the comorbidity of alcohol use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia.
Lai HM; Sitharthan T; Huang QR
Subst Abus; 2012; 33(2):138-45. PubMed ID: 22489586
[TBL] [Abstract][Full Text] [Related]
3. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity of mental disorders and alcohol- and drug-use disorders: analysis of New South Wales inpatient data.
Lai HM; Huang QR
Drug Alcohol Rev; 2009 May; 28(3):235-42. PubMed ID: 21462397
[TBL] [Abstract][Full Text] [Related]
5. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon.
Karam EG; Yabroudi PF; Melhem NM
Compr Psychiatry; 2002; 43(6):463-8. PubMed ID: 12439834
[TBL] [Abstract][Full Text] [Related]
7. Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence.
Arias F; Szerman N; Vega P; Mesias B; Basurte I; Morant C; Ochoa E; Poyo F; Babin F
Actas Esp Psiquiatr; 2013; 41(2):122-9. PubMed ID: 23592072
[TBL] [Abstract][Full Text] [Related]
8. Hospital admissions for obsessive-compulsive disorder in NSW, 1997 to 2010.
Brakoulias V; Sara G
Australas Psychiatry; 2011 Dec; 19(6):502-6. PubMed ID: 22077301
[TBL] [Abstract][Full Text] [Related]
9. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
Arendt M; Munk-Jørgensen P
Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
[TBL] [Abstract][Full Text] [Related]
10. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
[TBL] [Abstract][Full Text] [Related]
11. The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders.
Baker A; Turner A; Kay-Lambkin FJ; Lewin TJ
Addict Behav; 2009 Oct; 34(10):852-8. PubMed ID: 19299087
[TBL] [Abstract][Full Text] [Related]
12. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
[TBL] [Abstract][Full Text] [Related]
13. Co-occurring mental illness and substance use disorder among Australian prisoners.
Butler T; Indig D; Allnutt S; Mamoon H
Drug Alcohol Rev; 2011 Mar; 30(2):188-94. PubMed ID: 21355926
[TBL] [Abstract][Full Text] [Related]
14. Substance abuse in hospitalized psychiatric patients.
Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
Isr Med Assoc J; 2008 Oct; 10(10):672-5. PubMed ID: 19009943
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use and cannabis use disorders among individuals with mental illness.
Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
Compr Psychiatry; 2013 Aug; 54(6):589-98. PubMed ID: 23375264
[TBL] [Abstract][Full Text] [Related]
16. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.
Strakowski SM; DelBello MP; Fleck DE; Adler CM; Anthenelli RM; Keck PE; Arnold LM; Amicone J
Arch Gen Psychiatry; 2007 Jan; 64(1):57-64. PubMed ID: 17199055
[TBL] [Abstract][Full Text] [Related]
17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
18. Bipolar disorder in children and adolescents in Germany: national trends in the rates of inpatients, 2000-2007.
Holtmann M; Duketis E; Poustka L; Zepf FD; Poustka F; Bölte S
Bipolar Disord; 2010 Mar; 12(2):155-63. PubMed ID: 20402708
[TBL] [Abstract][Full Text] [Related]
19. Predicting clinically significant change in an inpatient program for people with severe mental illness.
Gonda T; Deane FP; Murugesan G
Aust N Z J Psychiatry; 2012 Jul; 46(7):651-8. PubMed ID: 22528976
[TBL] [Abstract][Full Text] [Related]
20. Co-morbidity and cannabis use in a mental health trust in South East England.
Trathen B; O'gara C; Sarkhel A; Sessay M; Rao H; Luty J
Addict Behav; 2007 Oct; 32(10):2164-77. PubMed ID: 17434688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
